Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each containing a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site. These compounds were synthesized by using click chemistry. Screening identified HDAC8-selective inhibitors including C149 (IC(50) = 0.070 μM), which was more potent than PCI-34058 (6) (IC(50) = 0.31 μM), a known HDAC8 inhibitor. Molecular modeling suggested that the phenylthiomethyl group of C149 binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity. The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI(50) = 3-80 μM). These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two aromatic hydroxamate derivatives show high selectivity for human HDAC8 (hHDAC8)”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [18]
Citations
Cites
Tornøe, C. W., Christensen, C., & Meldal, M. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo011148j · Cited by 8,696
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Yoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 713
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Self-citationGrozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Histone Deacetylase Inhibitors
Miller, T. A., Witter, D. J., & Belvedere, S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0303094 · Cited by 530
Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry
Lee, L. V., Mitchell, M. L., Huang, S.-J., Fokin, V. V., Sharpless, K. B., & Wong, C.-H. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0302836 · Cited by 432
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Histone Deacetylase Inhibitors: From Bench to Clinic
Paris, M., Porcelloni, M., Binaschi, M., & Fattori, D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7011408 · Cited by 367
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
Expression profile of class I histone deacetylases in human cancer tissues
Nakagawa, M., Oda, Y., Eguchi, T., Aishima, S.-I., Yao, T., Hosoi, F., Basaki, Y., Ono, M., Kuwano, M., Tanaka, M., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.769 · Cited by 341
Histone deacetylation in epigenetics: An attractive target for anticancer therapy
Mai, A., Massa, S., Rotili, D., Cerbara, I., Valente, S., Pezzi, R., Simeoni, S., & Ragno, R. (2005) · Medicinal Research Reviews · doi:10.1002/med.20024 · Cited by 319
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
Hu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Sung, C.-M., Liu, R., & Winkler, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908988199 · Cited by 309
Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide Derivatives
Suzuki, T., Ando, T., Tsuchiya, K., Fukazawa, N., Saito, A., Mariko, Y., Yamashita, T., & Nakanishi, O. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980565u · Cited by 293
Self-citationExploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Bressi, J. C., Jennings, A. J., Skene, R., Wu, Y., Melkus, R., Jong, R. D., O’Connell, S., Grimshaw, C. E., Navre, M., & Gangloff, A. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.091 · Cited by 261
Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401047 · Cited by 256
Dowling, D. P., Gantt, S. L., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2008) · Biochemistry · doi:10.1021/bi801610c · Cited by 200
Cloning and characterization of a novel human histone deacetylase, HDAC8
BUGGY, J. J., SIDERIS, M. L., MAK, P., LORIMER, D. D., MCINTOSH, B., & CLARK, J. M. (2000) · Biochemical Journal · doi:10.1042/bj3500199 · Cited by 197
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
Whitehead, L., Dobler, M. R., Radetich, B., Zhu, Y., Atadja, P. W., Claiborne, T., Grob, J. E., McRiner, A., Pancost, M. R., Patnaik, A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.030 · Cited by 164
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., & Hiebert, S. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.607-619.2003 · Cited by 161
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Waltregny, D., de Leval, L., Glénisson, W., Tran, S. L., North, B. J., Bellahcène, A., Weidle, U. H., Verdin, E. M., & Castronovo, V. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63320-2 · Cited by 145
Rapid Assembly and in Situ Screening of Bidentate Inhibitors of Protein Tyrosine Phosphatases
Srinivasan, R., Uttamchandani, M., & Yao, S. Q. (2006) · Organic Letters · doi:10.1021/ol052895w · Cited by 123
A Novel Potent Nicotinamide Phosphoribosyltransferase Inhibitor Synthesized via Click Chemistry
Colombano, G., Travelli, C., Galli, U., Caldarelli, A., Chini, M. G., Canonico, P. L., Sorba, G., Bifulco, G., Tron, G. C., & Genazzani, A. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9010669 · Cited by 114
Chen, P. C., Patil, V., Guerrant, W., Green, P., & Oyelere, A. K. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.050 · Cited by 112
Hu, M., Li, J., & Q. Yao, S. (2008) · Organic Letters · doi:10.1021/ol802286g · Cited by 110
Suzuki, T., Nagano, Y., Kouketsu, A., Matsuura, A., Maruyama, S., Kurotaki, M., Nakagawa, H., & Miyata, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049207j · Cited by 109
Self-citationSuzuki, T., Kouketsu, A., Itoh, Y., Hisakawa, S., Maeda, S., Yoshida, M., Nakagawa, H., & Miyata, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060554y · Cited by 105
Self-citationItoh, Y., Suzuki, T., Kouketsu, A., Suzuki, N., Maeda, S., Yoshida, M., Nakagawa, H., & Miyata, N. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm7009217 · Cited by 104
Self-citationIsoform-Selective Histone Deacetylase Inhibitors
Suzuki, T., Itoh, Y., & Miyata, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783885335 · Cited by 100
Self-citationDiscovery of histone deacetylase 8 selective inhibitors
Tang, W., Luo, T., Greenberg, E. F., Bradner, J. E., & Schreiber, S. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.134 · Cited by 92
Histone Deacetylase Inhibitors through Click Chemistry
Shen, J., Woodward, R., Kedenburg, J., Liu, X., Chen, M., Fang, L., Sun, D., & Wang, P. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005355 · Cited by 90
Benati, L., Bencivenni, G., Leardini, R., Nanni, D., Minozzi, M., Spagnolo, P., Scialpi, R., & Zanardi, G. (2006) · Organic Letters · doi:10.1021/ol0606637 · Cited by 86
An Unexpected Example of Protein‐Templated Click Chemistry
Suzuki, T., Ota, Y., Kasuya, Y., Mutsuga, M., KAWAMURA, Y., Tsumoto, H., Nakagawa, H., Finn, M. G., & Miyata, N. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002205 · Cited by 82
Self-citationDowling, D. P., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2010) · Biochemistry · doi:10.1021/bi1005046 · Cited by 81
Design, Synthesis, and Biological Activity of Boronic Acid-Based Histone Deacetylase Inhibitors
Suzuki, N., Suzuki, T., Ota, Y., Nakano, T., Kurihara, M., Okuda, H., Yamori, T., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900125m · Cited by 77
Self-citationSirion, U., Kim, H. J., Lee, J. H., Seo, J. W., Lee, B. S., Lee, S. J., Oh, S. J., & Yoon, D. (2007) · Tetrahedron Letters · doi:10.1016/j.tetlet.2007.04.048 · Cited by 77
Epigenetic Control Using Natural Products and Synthetic Molecules
Scior, T., & Garces-Eisele, S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776361067 · Cited by 73
Tan, L. P., Wu, H., Yang, P., Kalesh, K., Zhang, X., Hu, M., Srinivasan, R., & Yao, S. Q. (2009) · Organic Letters · doi:10.1021/ol9023419 · Cited by 72
Chromatin Modifications as Targets for New Anticancer Drugs
Schäfer, S., & Jung, M. (2005) · Archiv der Pharmazie · doi:10.1002/ardp.200500984 · Cited by 59
Rapid Assembly of Matrix Metalloprotease Inhibitors Using Click Chemistry
Wang, J., Uttamchandani, M., Li, J., Hu, M., & Yao, S. Q. (2006) · Organic Letters · doi:10.1021/ol061431a · Cited by 58
Methods of using click chemistry in the discovery of enzyme inhibitors
Srinivasan, R., Li, J., Ng, S. L., Kalesh, K., & Yao, S. Q. (2007) · Nature Protocols · doi:10.1038/nprot.2007.323 · Cited by 50
Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida, M., Shimazu, T., & Matsuyama, A. (2003) · PubMed · Cited by 49
Structure-based optimization of click-based histone deacetylase inhibitors
Hou, J., Feng, C., Li, Z., Fang, Q., Wang, H., Gu, G., Shi, Y., Liu, P., Xu, F., Yin, Z., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.04.027 · Cited by 38
Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond
Konstantinopoulos, P. A., Karamouzis, M. V., & Papavassiliou, A. G. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.5.569 · Cited by 38
Hein, J. E., Krasnova, L. B., Iwasaki, M., & Fokin, V. V. (2011) · Organic Syntheses · doi:10.1002/0471264229.os088.23 · Cited by 31
(2011) · Organic Syntheses · doi:10.15227/orgsyn.088.0238 · Cited by 30
Papeo, G., Posteri, H., Vianello, P., & Varasi, M. (2004) · Synthesis · doi:10.1055/s-2004-831254 · Cited by 23
Synthesis and biological evaluation of triazole analogues of antillatoxin
Goto, R., Okura, K., Sakazaki, H., Sugawara, T., Matsuoka, S., & Inoue, M. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.05.012 · Cited by 11
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Rostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4
Research works printed but not linked: 2
- Yoshida M., 2003, Prog. Cell Cycle Res., 5, 269
- Nakagawa M., 2007, Oncol. Rep., 18, 769
Cited by
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Zheng, Y.-C., Duan, Y.-C., Ma, J.-L., Xu, R.-M., Zi, X., Lv, W.-L., Wang, M.-M., Ye, X.-W., Zhu, S., Mobley, D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401002r · Cited by 218
Inhibitors of histone deacetylase as antitumor agents: A critical review
Manal, M., Chandrasekar, M. J. N., Gomathi Priya, J., & Nanjan, M. J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.005 · Cited by 216
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
Wang, X., Huang, B., Liu, X., & Zhan, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.004 · Cited by 190
Metadata
- Authors
- Suzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., Iida, S., Ueda, R., Shirahige, K., & Miyata, N.
- Affiliations
- Kyoto Prefectural University of Medicine (JP)
- Nagoya City University (JP)
- The University of Tokyo (JP)
- Nagahama Institute of Bio-Science and Technology (JP)
- Corresponding author
- Suzuki, Takayoshi
- Miyata, Naoki
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-11-12
- Volume
- 55
- Issue
- 22
- Pages
- 9562-9575
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2029671140
- Cited by
- 165
- References
- 63
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 15 · 2018: 10 · 2017: 13 · 2016: 15 · 2015: 11 · 2014: 15 · 2013: 6
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24659050, 24689007)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- HDAC8, HDAC8 inhibitors, selective inhibitors, click chemistry, triazole linkers, zinc-binding groups, hydrophobic pocket, T-cell lymphoma, neuroblastoma, anticancer agents
- MeSH terms
- Antineoplastic Agents, Histone Deacetylases, Humans, Models, Molecular, Neuroblastoma, Repressor Proteins, Tumor Cells, Cultured, Blotting, Western, Lymphoma, T-Cell, Apoptosis, Cell Proliferation, Small Molecule Libraries, Histone Deacetylase Inhibitors, Click Chemistry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.